CN Patent

CN113365618A — 改善睡眠或睡醒后表现

Assigned to Wandailan Pharmaceutical Co · Expires 2021-09-07 · 5y expired

What this patent protects

本发明总体上涉及改善睡眠、睡醒后表现或两者，更特别地涉及在不引起将会减弱个人操作机械或机动车辆的能力的睡醒后影响的情况下进行改善。

USPTO Abstract

本发明总体上涉及改善睡眠、睡醒后表现或两者，更特别地涉及在不引起将会减弱个人操作机械或机动车辆的能力的睡醒后影响的情况下进行改善。

Drugs covered by this patent

Patent Metadata

Patent number: CN113365618A
Jurisdiction: CN
Classification: —
Expires: 2021-09-07
Drug substance claim: No
Drug product claim: No
Assignee: Wandailan Pharmaceutical Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.